Important Role of CYP2J2 in Protein Kinase Inhibitor Degradation: A Possible Role in Intratumor Drug Disposition and Resistance-Reference-Cited by-同舟云学术

Important Role of CYP2J2 in Protein Kinase Inhibitor Degradation: A Possible Role in Intratumor Drug Disposition and Resistance

Published:2014-05-12 Issue:5 Volume:9 Page:e95532
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Narjoz Céline,Favre Amélie,McMullen Justin,Kiehl Philippe,Montemurro Michael,Figg William D.,Beaune Philippe,de Waziers Isabelle,Rochat Bertrand

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference47 articles.

1. Molecular aspects of cancer cell resistance to chemotherapy;M Rebucci;Biochem Pharmacol,2013

2. Role of cytochrome p450 activity in the fate of anticancer agents and in drug resistance: focus on tamoxifen, paclitaxel and imatinib metabolism;B Rochat;Clin Pharmacokinet,2005

3. Clinical pharmacokinetics of tyrosine kinase inhibitors;NP van Erp;Cancer Treat Rev,2009

4. Role of Influx and Efflux Systems and Xenobiotic Metabolizing Enzymes in the Intratumoral Disposition of Anti-Cancer Agents;B Rochat;Curr Cancer Drug Targets,2009

5. Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet;I Bièche;Genomics,2007

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CYP2J2-mediated metabolism of arachidonic acid in heart: A review of its kinetics, inhibition and role in heart rhythm control;Pharmacology & Therapeutics;2024-06

2. Bilobetin induces apoptosis in human hepatocellular carcinoma cells via ROS level elevation and inhibition of CYP2J2;Arabian Journal of Chemistry;2023-09

3. Potential of Cytochrome P450, a Family of Xenobiotic Metabolizing Enzymes, in Cancer Therapy;Antioxidants & Redox Signaling;2023-04-01

4. SPK1/S1P axis confers gastrointestinal stromal tumors (GISTs) resistance of imatinib;Gastric Cancer;2022-08-24

5. Cardiomyocyte-specific CYP2J2 and its therapeutic implications;Expert Opinion on Drug Metabolism & Toxicology;2022-08-03